Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹10595 Cr.
Stock P/E
70.5
P/B
5.4
Current Price
₹882
Book Value
₹ 164.4
Face Value
2
52W High
₹1020.4
52W Low
₹ 732
Dividend Yield
0%

Medplus Health Servi Overview

Business

Medplus Health Services Ltd. is India's third-largest pharmacy retail chain based on the number of stores as of FY23. The company operates a chain of retail pharmacies primarily selling prescription and over-the-counter (OTC) medicines. Beyond pharmaceuticals, it also retails a range of other products including FMCG (Fast-Moving Consumer Goods), general merchandise, nutritional supplements, and medical devices. Its core business model revolves around offering a wide assortment of products, often at discounted prices, through its extensive network of physical stores and a growing omnichannel presence, aiming for customer convenience and loyalty. The company makes money through direct sales of these products to consumers.

Revenue Mix

Medplus primarily operates as a single business segment: pharmacy retail. The vast majority of its revenue is generated from the sale of pharmaceutical products (prescription and OTC medicines). Other segments contributing to revenue, albeit smaller, include:

FMCG & General Merchandise: Sale of daily utility items, personal care products, and other non-pharma goods.

Pathological Services: Offers basic diagnostic services through some outlets.

While specific revenue percentages for each sub-category are not publicly segmented in detail, prescription and OTC medicines form the dominant share.

Industry

The Indian pharmacy retail industry is large, growing, and historically highly fragmented, dominated by standalone pharmacies. However, it is rapidly transitioning towards organized retail and e-pharmacy models. Medplus is positioned as the third-largest organized pharmacy retailer in India by store count, behind players like Apollo Pharmacy and Reliance Retail (which includes Netmeds). It has a strong presence, particularly in South India, and is expanding into other regions. The company competes with traditional standalone pharmacies, other organized retail chains, hospital-owned pharmacies, and a growing number of online e-pharmacy platforms.

MOAT

Scale and Network Effect: With over 4,000 stores (as of recent data), Medplus benefits from a significant physical presence across various cities and towns, providing geographical reach and customer proximity. This scale can lead to better procurement terms and operational efficiencies.

Brand Recognition & Trust: An established brand over two decades has built a level of trust among its customer base, particularly in its core markets.

Operational Efficiency & Technology: Focus on robust supply chain management, inventory optimization, and technology integration (like its proprietary point-of-sale system and loyalty programs) helps manage operations across a large network.

Value Proposition: Its strategy of offering discounts and loyalty programs helps in customer retention in a price-sensitive market.

Growth Drivers

Store Network Expansion: Continued aggressive expansion into new geographical territories and deeper penetration in existing markets remains a primary growth driver.

Shift to Organized Retail: The ongoing transition from unorganized standalone pharmacies to organized retail chains provides a significant market opportunity.

Increasing Healthcare Spending: Rising disposable incomes, greater health awareness, and an aging population are contributing to higher demand for pharmaceutical and wellness products.

Omnichannel Strategy: Integration of its physical stores with its online platform (Medplus Mart app) aims to capture a larger customer base and enhance convenience.

Private Label Growth: Expansion of its private label products, which typically offer higher margins, can drive profitability and revenue growth.

Risks

Intense Competition: The Indian pharmacy retail market is highly competitive, facing strong players like Apollo Pharmacy, Reliance Retail, and numerous standalone pharmacies, as well as an increasing number of e-pharmacies, potentially leading to price wars and margin pressure.

Regulatory Changes: The pharmaceutical sector is subject to stringent regulations regarding drug pricing, licensing, and e-pharmacy operations. Any adverse changes could impact the business model or profitability.

Supply Chain and Inventory Management: Managing a vast and perishable inventory across thousands of stores requires sophisticated logistics, and any disruptions or inefficiencies can lead to losses.

Profitability Pressure from Expansion: Aggressive store expansion requires significant capital expenditure and new stores typically take time to achieve profitability, potentially impacting overall margins in the short term.

Technological Disruptions: Failure to adapt to evolving digital trends and competition from more agile e-pharmacy models could pose a risk.

Management & Ownership

Medplus was founded by Dr. Madhukar Gangadi, who serves as the Managing Director and CEO. The promoter group, led by Dr. Gangadi, holds a significant stake in the company, indicating strong alignment with business performance. The management team has extensive experience in the retail and pharmaceutical sectors, demonstrating a focus on operational efficiency, technology adoption, and expansion strategies. The ownership structure also includes institutional investors, reflecting broader market confidence.

Outlook

Medplus operates in a structural growth story within India's healthcare and retail sector, benefiting from the formalization of pharmacy retail and increasing healthcare awareness. The company's established brand, extensive store network, and focus on operational efficiency position it to capture a larger share of the growing market. However, its growth trajectory is contingent on navigating intense competition from well-capitalized rivals (both offline and online), managing the capital requirements and gestation periods for new store expansion, and adapting to potential regulatory shifts. The successful execution of its omnichannel strategy and the ability to maintain healthy margins amidst competitive pricing will be key determinants of its long-term success.

Medplus Health Servi Share Price

Live · BSE / NSE · Inception: 2006
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Medplus Health Servi Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 1441 1490 1489 1576 1561 1510 1543 1679 1806 1864
Other Income 10 10 9 12 13 16 15 17 18 21
Total Income 1451 1501 1498 1588 1574 1525 1558 1697 1824 1885
Total Expenditure 1350 1385 1395 1452 1429 1373 1412 1530 1648 1695
Operating Profit 102 116 102 136 145 152 146 166 177 190
Interest 24 25 25 25 26 27 27 29 31 33
Depreciation 57 59 60 63 62 64 66 69 73 76
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 20 32 18 48 57 61 53 69 73 80
Provision for Tax 6 -2 3 9 11 10 10 13 15 16
Profit After Tax 14 34 14 39 46 51 42 56 58 64
Adjustments 0 -0 0 0 0 0 0 -0 0 0
Profit After Adjustments 14 33 14 39 46 51 42 56 58 64
Adjusted Earnings Per Share 1.1 2.8 1.2 3.2 3.8 4.3 3.5 4.6 4.8 5.3

Medplus Health Servi Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1368 1733 2011 2132 2273 2871 3069 3779 4558 5625 6136 6892
Other Income 4 9 8 7 10 17 22 31 46 40 49 71
Total Income 1373 1742 2020 2139 2283 2888 3091 3811 4604 5665 6185 6964
Total Expenditure 1333 1691 1935 2073 2216 2737 2840 3490 4276 5254 5633 6285
Operating Profit 40 50 85 66 67 151 251 320 327 411 552 679
Interest 17 22 25 28 16 47 67 83 99 114 119 120
Depreciation 9 10 11 12 14 75 88 119 182 224 250 284
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 14 19 48 26 37 29 95 118 47 73 183 275
Provision for Tax 6 10 19 -17 16 28 32 23 -3 8 33 54
Profit After Tax 7 9 29 42 21 2 63 95 50 66 150 220
Adjustments 0 -0 -0 0 0 0 1 1 -0 -0 0 0
Profit After Adjustments 7 9 29 42 21 2 64 96 50 65 150 220
Adjusted Earnings Per Share 39.4 47.8 152.3 194.1 95.8 8.2 285.1 8 4.2 5.5 12.6 18.2

Medplus Health Servi Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 154 149 160 303 325 528 731 1418 1491 1578 1741
Minority's Interest 0 0 0 0 0 1 1 -1 -1 -1 -1
Borrowings 62 65 54 8 0 0 0 0 0 0 0
Other Non-Current Liabilities 5 18 34 -27 10 327 399 647 797 849 992
Total Current Liabilities 210 269 276 325 337 498 445 559 477 575 625
Total Liabilities 430 501 525 610 672 1354 1575 2624 2764 3002 3356
Fixed Assets 67 77 81 83 90 419 517 799 1138 1242 1296
Other Non-Current Assets 46 48 49 69 107 102 105 193 146 143 168
Total Current Assets 317 376 395 458 475 833 953 1632 1481 1616 1891
Total Assets 430 501 525 610 672 1354 1575 2624 2764 3002 3356

Medplus Health Servi Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 13 46 31 21 35 -47 9 -28 -121 228 91
Cash Flow from Operating Activities -19 -17 34 32 82 -7 3 170 90 144 540
Cash Flow from Investing Activities -15 -32 -15 -18 -20 -28 -35 -703 429 -83 -318
Cash Flow from Financing Activities 66 35 -29 -1 -72 90 -6 440 -170 -198 -228
Net Cash Inflow / Outflow 32 -15 -10 14 -10 56 -37 -93 350 -137 -5
Closing Cash & Cash Equivalent 45 31 21 35 24 9 -28 -121 228 91 86

Medplus Health Servi Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 39.43 47.84 152.33 194.06 95.77 8.22 285.08 8.03 4.17 5.48 12.56
CEPS(Rs) 85.43 100.33 212.89 251.21 159.72 350.98 675.81 17.94 19.42 24.24 33.42
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 716.21 694.75 752.08 1363.1 1450.49 2378.5 3044.19 117.89 122.44 129.47 143.22
Core EBITDA Margin(%) 2.61 2.39 3.81 2.75 2.5 4.65 7.32 7.54 6.08 6.51 8.09
EBIT Margin(%) 2.28 2.33 3.65 2.5 2.32 2.65 5.19 5.24 3.16 3.28 4.86
Pre Tax Margin(%) 1.01 1.08 2.38 1.2 1.61 1.02 3.04 3.08 1.02 1.29 2.95
PAT Margin (%) 0.55 0.52 1.43 1.99 0.92 0.06 2.01 2.47 1.08 1.15 2.41
Cash Profit Margin (%) 1.18 1.1 2 2.57 1.53 2.67 4.83 5.59 5.01 5.08 6.43
ROA(%) 1.73 1.94 5.62 7.47 3.26 0.18 4.31 4.51 1.86 2.27 4.73
ROE(%) 5.51 6.78 21.06 19.26 6.81 0.43 10.51 9.07 3.5 4.36 9.21
ROCE(%) 10.02 12.04 20.61 13.06 11.77 14.34 21.69 16.56 9.56 12.19 18.22
Receivable days 1.03 0.77 0.53 1.09 1.53 0.96 0.69 0.54 0.58 0.84 0.9
Inventory Days 67.6 59.37 58.51 59.74 60.81 65.93 81.18 79.28 81.27 79.52 78.76
Payable days 34.09 28.02 24.9 25.21 28.85 31 28.76 24.13 25.98 21.33 21.71
PER(x) 0 0 0 0 0 0 0 125.8 156.11 125.87 60.48
Price/Book(x) 0 0 0 0 0 0 0 8.57 5.32 5.33 5.3
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.09 0.1 0.08 0.05 0.02 -0.01 0.01 3.22 1.64 1.44 1.42
EV/Core EBITDA(x) 3.07 3.44 1.92 1.59 0.82 -0.23 0.07 37.97 22.86 19.69 15.8
Net Sales Growth(%) 0 26.64 16.07 5.99 6.61 26.31 6.92 23.13 20.59 23.42 9.09
EBIT Growth(%) 0 29.35 81.5 -27.21 -1.32 44.56 113.38 23.63 -27.38 28.24 61.55
PAT Growth(%) 0 21.32 218.43 46.9 -50.65 -91.42 3417.89 50.08 -47.1 30.88 129.09
EPS Growth(%) 0 21.31 218.43 27.39 -50.65 -91.42 3368.17 -97.18 -48.06 31.32 129.29
Debt/Equity(x) 1.07 1.46 1.24 0.55 0.33 0.2 0.2 0.1 0 0 0
Current Ratio(x) 1.51 1.4 1.43 1.41 1.41 1.67 2.14 2.92 3.11 2.81 3.03
Quick Ratio(x) 0.3 0.25 0.22 0.29 0.24 0.38 0.46 1.28 0.71 0.48 0.87
Interest Cover(x) 1.79 1.86 2.89 1.92 3.27 1.63 2.41 2.42 1.48 1.65 2.54
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.01 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +9% +18% +16% +16%
Operating Profit CAGR +34% +20% +30% +30%
PAT CAGR +127% +16% +137% +36%
Share Price CAGR -1% +4%
ROE Average +9% +6% +7% +9%
ROCE Average +18% +13% +16% +15%

Medplus Health Servi Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 40.22 %
FII 15.53 %
DII (MF + Insurance) 27.82 %
Public (retail) 59.78 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 40.4540.3940.3940.3940.3940.3440.3240.2940.2940.22
FII 12.9714.9414.8514.7215.2315.6116.4216.5416.8315.53
DII 25.1822.4722.1727.9725.6526.1926.0326.5226.5727.82
Public 59.5559.6159.6159.6159.6159.6659.6859.7159.7159.78
Others 0000000000
Total 100100100100100100100100100100

Medplus Health Servi Peer Comparison

Retailing Edit Columns

Medplus Health Servi Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Medplus Health Servi Pros & Cons

Pros

  • Company has delivered good profit growth of 137% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Promoter holding is low: 40.22%.
  • Company has a low return on equity of 6% over the last 3 years.
  • Debtor days have increased from 21.33 to 21.71days.
  • Stock is trading at 5.4 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp